The C360 line “is key to our long-term strategy and represents a significant opportunity for growth,” said Massimo Calafiore, executive vice president of global business units at NuVasive.
NuVasive also launched the Anterior Cervical Plating system, which aims to reduce post-op complications such as dysphagia, malalignment and adjacent level ossification.
The C360 portfolio also includes Reline Cervical, a posterior fixation system expected to be commercially available in 2021.
More articles on devices:
Dr. Daniel Lieberman: How hospitals will react to outpatient migration & what’s next for spine at ASCs
Illinois Bone & Joint Institute CEO on M&As in 2020 and future strategy
Nick Saban lauds orthopedic surgeon named as SEC Team Physician of the Year
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
